Pulmonary Embolism
|
disease |
Respiratory Tract Diseases; Cardiovascular Diseases
|
Pathologic Function
|
93
|
16
|
0.100 |
None |
|
0 |
|
|
|
Cerebral Hemorrhage
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Pathologic Function
|
122
|
78
|
0.100 |
None |
|
0 |
|
|
|
Thrombophlebitis
|
disease |
Cardiovascular Diseases
|
Pathologic Function
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Retinal Diseases
|
group |
Eye Diseases
|
Disease or Syndrome
|
714
|
56
|
0.100 |
None |
|
0 |
|
|
|
Abnormal pigmentation
|
phenotype |
|
Finding
|
58
|
5
|
0.100 |
None |
|
0 |
|
|
|
Venous Insufficiency
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
17
|
1
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of the cerebral vasculature
|
disease |
|
Anatomical Abnormality
|
18
|
|
0.100 |
None |
|
0 |
|
|
|
Purpura
|
disease |
Pathological Conditions, Signs and Symptoms; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
68
|
1
|
0.100 |
None |
|
0 |
|
|
|
Retinopathy, CTCAE
|
phenotype |
|
Finding
|
108
|
|
0.100 |
None |
|
0 |
|
|
|
Warfarin-induced skin necrosis
|
phenotype |
|
Finding
|
2
|
|
0.100 |
None |
|
0 |
|
|
|
Skin Ulcer
|
phenotype |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
151
|
1
|
0.100 |
None |
|
0 |
|
|
|
Gangrene
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
69
|
4
|
0.100 |
None |
|
0 |
|
|
|
Superficial Thrombophlebitis, CTCAE
|
phenotype |
|
Finding
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Arterial thrombosis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
33
|
1
|
0.100 |
None |
|
0 |
|
|
|
Metastatic Prostate Carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
362
|
24
|
0.090 |
None |
1.000 |
9 |
|
1999 |
2019 |
Metastasis from malignant tumor of prostate
|
disease |
|
Neoplastic Process
|
342
|
18
|
0.090 |
None |
1.000 |
9 |
|
1999 |
2019 |
Familial lichen amyloidosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
230
|
24
|
0.090 |
None |
1.000 |
9 |
|
2009 |
2020 |
Pyruvate Carboxylase Deficiency Disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
14
|
33
|
0.090 |
None |
1.000 |
9 |
|
1987 |
2018 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.080 |
None |
1.000 |
8 |
|
1998 |
2019 |
Factor V Leiden mutation
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
86
|
46
|
0.080 |
None |
1.000 |
8 |
2
|
1997 |
2018 |
Hereditary protein S deficiency
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
2
|
|
0.080 |
None |
1.000 |
8 |
|
1995 |
2016 |
Lower Urinary Tract Symptoms
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
77
|
30
|
0.050 |
None |
1.000 |
5 |
|
2017 |
2019 |
Lupus anticoagulant disorder
|
disease |
Pathological Conditions, Signs and Symptoms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
66
|
14
|
0.050 |
None |
1.000 |
5 |
|
1994 |
2013 |
Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.050 |
None |
1.000 |
5 |
|
1990 |
2019 |
Progression of prostate cancer
|
disease |
|
Neoplastic Process
|
398
|
7
|
0.050 |
None |
0.800 |
5 |
|
2008 |
2020 |